Ask HopeStage to review this study with me
Study ID: NCT03242772. We help you review the study, but cannot decide medical eligibility.
TerminatedNCT03242772
Impact of Combined Medication and Behavioral Treatment for ASD & ADHD
This study has public registry information. It focuses on ADHD and currently lists study information in the United States.
ADHD, Autism spectrumBehavioralFrom 36 Months to 131 Months
Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
Your next step
The official record suggests a mix of remote and in-person participation through a clinic, with sites including Duke Center for Autism and Brain Development in Durham. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually being able to understand the study and consent and matching the main diagnosis, while common reasons not to take part include major medical issues that could make participation unsuitable and other treatments that could interfere with the study. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: December 14, 2018
- Recruitment status
- Terminated
- Estimated enrollment
- Not clearly listed
- Sponsor
- Duke University
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioral / psychological / psychosocial
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 36 Months to 131 Months
- Official registry ID
- NCT03242772
- Official title
- Impact of Combined Medication and Behavioral Treatment for ASD & ADHD
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT03242772. We help you review the study, but cannot decide medical eligibility.
For you
Taking part may help test a support approach in real life.
It requires regular follow-up, often through questionnaires or interviews.
Mixes in-person and remote participation.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring psychotherapy or therapy for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study. Phase is mainly useful to check for medication studies and some device studies.
Who might this study be for?
This study may concern people with adhd; age range: From 36 Months to 131 Months. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Could this study affect my mood, habits, motivation, or stress?
Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Duke University, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that this study is not currently recruiting. Check the official registry for the reason and latest status.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
TerminatedNCT01733680
Amiloride Hydrochloride as an Effective Treatment for ADHD
This study has public registry information. It focuses on ADHD and currently lists study information in the United States.
TerminatedNCT02094612
Effectiveness of the Quotient® ADHD Assessment in a System of Care
This study has public registry information. It focuses on ADHD and currently lists study information in the United States.
TerminatedNCT03638466
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD
This study has public registry information. It focuses on ADHD and currently lists study information in the United States.